Ensysce Biosciences Inc. (ENSC:NASDAQ) jumped higher at $0.87, representing a gain of 73.1%. On Thu, Jun 30, 2022, ENSC:NASDAQ touched a New 2-Week High of $0.87. The stock appeared on our News Catalysts scanner on Mon, Jun 27, 2022 at 11:08 AM in the 'MISCELLANEOUS' category. From Fri, Jun 17, 2022, the stock recorded 62.50% Up Days and 55.56% Green Days
The stock spiked on Wed, Apr 06, 2022 at $1.65 with a volume of 11M+.
About Ensysce Biosciences Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 73.09%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Fast Radius Inc. (FSRD:NASDAQ), 37.23%
- Yoshitsu Co. Ltd (TKLF:NASDAQ), 36.29%
- Rapid Micro Biosystems Inc. (RPID:NASDAQ), 35.22%
- Aytu BioScience, Inc. (AYTU:NASDAQ), 33.64%
- RiceBran Technologies (RIBT:NASDAQ), 29.57%
- Volcon Inc. (VLCN:NASDAQ), 26.9%
- Tuniu Corporation (TOUR:NASDAQ), 25.99%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 23.36%